NewLimit raises $435M Series C led by Founders Fund

LATEST: ⚡️ Brian Armstrong's anti-aging biotech Newlimit raised $435M in a Series C, tripling its valuation to $3.1B, and plans to start human trials next year. https://t.co/GPmRm6UBMV